+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Intraoperative Neuromonitoring Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product; Source; Application; Modality; and End User, and Country

  • ID: 5180785
  • Report
  • September 2020
  • Region: North America
  • 128 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Accurate Monitoring
  • Moberg Research, Inc
  • NuVasive, Inc
  • SpecialtyCare
  • MORE
The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019; it is estimated to grow at a CAGR of 7.9% from 2019 to 2027.

The intraoperative neuromonitoring market in North America grows primarily due to rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring; however, the lack of skilled professionals restrains the growth of the market. Additionally, increasing research activities in nerve monitoring field and integration of artificial intelligence (AI) technology with neuromonitoring are expected to fuel the growth of the intraoperative neuromonitoring market during the forecast period.

Intraoperative neurophysiological monitoring (IOM), an integral part of most of the surgical procedures, prevents the neurological damage that may cause during surgeries. It also identifies the neural structures, thereby preventing the post-operative impairments. IOM employs a wide range of modalities such as motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).

Neuromonitoring provides real-time alerts during the surgery and helps the surgeon make informed decisions to avoid neural injuries; also, many integrated technologies enhance the patient outcome. Many studies demonstrate that a combination of advanced optical imaging with an AI algorithm generate an accurate, real-time intraoperative diagnosis of brain tumors.

For instance, Nervio has developed an innovative, autonomous, and intraoperative neuromonitoring solution by using AI technology. The system offers real-time alerts and clinical recommendations during the surgery. The company aims to make neuromonitoring accessible and affordable. Moreover, Al is increasingly being utilized in treating neurological disorders. For example, in October 2019, Henry Ford Health System and Mon4t launched a pilot study related to AI and Parkinson's disease. Thus, these innovations drive the growth of the market.

The patients who go through critical surgeries such as spinal surgery, neurosurgery, or ENT surgery need physical attention and are required to undergo a few procedures in clinics/hospitals. The procedures include intraoperative neuromonitoring by systems, services, and accessories. During surgical treatments and other procedures, doctors and healthcare specialists are in direct contact with patients. Due to the ongoing COVID-19 pandemic situation in North America, it is crucial to maintain social distancing in order to avoid direct exposure to body fluids. Considering these facts, many hospitals and clinics are hesitating to schedule these surgeries unless it is critical. Therefore, this scenario affects the growth of the intraoperative neuromonitoring market in North America.

In 2019, the systems segment accounted for the largest share of the North America intraoperative neuromonitoring market. Systems in intraoperative monitoring have become a crucial factor in neurosurgery as these offer an early warning concerning motor and sensory functions during surgery, thus it yields better results and avoids post-operative neurophysiological deficits. Moreover, market players are continuously developing advanced products to gain high market share.

A few major secondary sources referred to while preparing the North America intraoperative neuromonitoring market report are World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), Orthopaedic Research Society, Canadian Patient Safety Institute (CPSI), and American Association of Neurological Surgeons.

Reasons to Buy
  • It provides understanding of the North America, intraoperative neuromonitoring market landscape and identifies intraoperative neuromonitoring market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America intraoperative neuromonitoring market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the intraoperative neuromonitoring market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of intraoperative neuromonitoring market performance of various segments pertaining to the North America intraoperative neuromonitoring market.
  • It provides intraoperative neuromonitoring market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Accurate Monitoring
  • Moberg Research, Inc
  • NuVasive, Inc
  • SpecialtyCare
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Intraoperative Neuromonitoring Market - By Product
1.3.2 North America Intraoperative Neuromonitoring Market - By Source
1.3.3 North America Intraoperative neuromonitoring Market- By Application
1.3.4 North America Intraoperative neuromonitoring Market- By Modality
1.3.5 North America Intraoperative neuromonitoring Market- By End User
1.3.6 North America Intraoperative Neuromonitoring Market - By Country

2. North America Intraoperative Neuromonitoring Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Intraoperative Neuromonitoring Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Intraoperative Neuromonitoring Market - North America PEST Analysis
4.3 Expert Opinion

5. North America Intraoperative Neuromonitoring Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences of Neurological Disorders
5.1.2 Increasing Technological Advancements in the Field of Neuromonitoring
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Increasing Research Activities in the Nerve Monitoring Field
5.4 Future Trends
5.4.1 Integration of Artificial Intelligence (AI) in Neuro-Monitoring
5.5 Impact analysis

6. Intraoperative Neuromonitoring Market - North America Analysis
6.1 North America Intraoperative neuromonitoring Market Revenue Forecasts and Analysis

7. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 - By Product
7.1 Overview
7.2 North America Intraoperative Neuromonitoring Market, By Product 2019 & 2027 (%)
7.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Systems
7.3.1 Overview
7.3.2 North America Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Accessories
7.4.1 Overview
7.4.2 North America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Services
7.5.1 Overview
7.5.2 North America Services Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 - By Source
8.1 Overview
8.2 North America Intraoperative Neuromonitoring Market, By Source 2019 & 2027 (%)
8.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Source (US$ Mn)
8.3 Insourced Monitoring
8.3.1 Overview
8.3.2 North America Insourced Monitoring Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Outsourced Monitoring
8.4.1 Overview
8.4.2 North America Outsourced Monitoring Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 - By Application
9.1 Overview
9.2 North America Intraoperative Neuromonitoring Market, By Application 2019 & 2027 (%)
9.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Spinal Surgery
9.3.1 Overview
9.3.2 North America Spinal Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Neurosurgery
9.4.1 Overview
9.4.2 North America Neurosurgery Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Vascular Surgery
9.5.1 Overview
9.5.2 North America Vascular Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.6 ENT Surgery
9.6.1 Overview
9.6.2 North America ENT Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Orthopaedic Surgery
9.7.1 Overview
9.7.2 North America Orthopaedic Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Other Surgeries
9.8.1 Overview
9.8.2 North America Other Surgeries Market Revenue and Forecast to 2027 (US$ Mn)

10. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 - By Modality
10.1 Overview
10.2 North America Intraoperative Neuromonitoring Market, By Modality 2019 & 2027 (%)
10.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
10.3 Somatosensory Evoked Potentials
10.3.1 Overview
10.3.2 North America Somatosensory Evoked Potentials Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Motor Evoked Potentials
10.4.1 Overview
10.4.2 North America Motor Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Electromyography
10.5.1 Overview
10.5.2 North America Electromyography Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Electroencephalography
10.6.1 Overview
10.6.2 North America Electroencephalography Market Revenue and Forecasts to 2027 (US$ Mn)
10.7 Brainstem Auditory Evoked Potentials
10.7.1 Overview
10.7.2 North America Brainstem Auditory Evoked Potentials Market Revenue and Forecast to 2027 (US$ Mn)
10.8 Visual Evoked Potentials
10.8.1 Overview
10.8.2 North America Visual Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)

11. North America Intraoperative Neuromonitoring Market Analysis - By End-User
11.1 Overview
11.2 North America Intraoperative Neuromonitoring Market, By End-User 2019-2027 (%)
11.2.1 North America Intraoperative neuromonitoring Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
11.3 Hospitals
11.3.1 Overview
11.3.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

12. Intraoperative neuromonitoring Market Revenue and Forecasts To 2027 - Geographical Analysis
12.1 North America Intraoperative neuromonitoring Market Revenue and Forecasts To 2027
12.1.1 North America: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.2 North America Intraoperative Neuromonitoring Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America Intraoperative Neuromonitoring Market, by Source- Revenue and Forecast to 2027 (USD Million)
12.1.4 North America Intraoperative Neuromonitoring Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.5 North America Intraoperative Neuromonitoring Market, by Modality - Revenue and Forecast to 2027 (USD Million)
12.1.6 North America Intraoperative Neuromonitoring Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Intraoperative Neuromonitoring Market, by Country, 2019 & 2027 (%)
12.1.8 US: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.8.1 US: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.8.2 US Intraoperative Neuromonitoring Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.8.3 US Intraoperative Neuromonitoring Market, by Source- Revenue and Forecast to 2027(USD Million)
12.1.8.4 US Intraoperative Neuromonitoring Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.8.5 US Intraoperative Neuromonitoring Market, by Modality - Revenue and Forecast to 2027 (USD Million)
12.1.8.6 US Intraoperative Neuromonitoring Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.9 Canada: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Canada: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 Canada Intraoperative Neuromonitoring Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Canada Intraoperative Neuromonitoring Market, by Source- Revenue and Forecast to 2027(USD Million)
12.1.9.4 Canada Intraoperative Neuromonitoring Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Canada Intraoperative Neuromonitoring Market, by Modality - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Canada Intraoperative Neuromonitoring Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 Mexico: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Mexico: Intraoperative Neuromonitoring Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Mexico Intraoperative Neuromonitoring Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Mexico Intraoperative Neuromonitoring Market, by Source- Revenue and Forecast to 2027(USD Million)
12.1.10.4 Mexico Intraoperative Neuromonitoring Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Mexico Intraoperative Neuromonitoring Market, by Modality - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Mexico Intraoperative Neuromonitoring Market, by End User - Revenue and Forecast to 2027 (USD Million)

13. Impact of COVID-19 Pandemic on North America Intraoperative neuromonitoring Market
13.1 North America: Impact Assessment of COVID-19 Pandemic

14. Company Profiles
14.1 Accurate Monitoring
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Computational Diagnostics, Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 IntraNerve Neuroscience Holdings, LLC
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Natus Medical Incorporated
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 NuVasive, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 SpecialtyCare
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Moberg Research, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

15. Appendix
15.1 About the Publisher
15.2 Word Index
Note: Product cover images may vary from those shown
3 of 3
  • Accurate Monitoring
  • Computational Diagnostics, Inc
  • IntraNerve Neuroscience Holdings, LLC
  • Natus Medical Incorporated
  • NuVasive, Inc
  • SpecialtyCare
  • Moberg Research, Inc
Note: Product cover images may vary from those shown
Adroll
adroll